Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial

NCT05863195 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT05863195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05863195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 3
Overall status
Recruiting
Start date
April 10, 2024
Completion date
June 30, 2029
Enrollment
408 (estimated)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal carcinoma, metastatic malignant neoplasm in the liver, stage iv colorectal cancer ajcc v8, unresectable colorectal carcinoma